Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APD515 for relief of xerostomia in patients with cancer
2011-000978-53Phase 2Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in xerostomia comparing APD515 with Placebo (2 arms). Primary endpoint: Change in mouth dryness VAS score. Started Apr 2011; status: completed.
02
Drugs
bethanechol
03
Conditions
xerostomia
Beyond the preview
Go deeper on 2011-000978-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000978-53.